Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07197762 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults

StatusRecruiting
PhasePhase 4
Started2025-11-04
View on ClinicalTrials.gov ↗

Amendment history

2025-12-19
Not Yet Recruiting→Recruiting Study Identification, Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-10→confirmed 2025-11-04
Study sitesdetails revised at 2 of 2 sites
2025-09-26
Original filing
The goal of this clinical trial is to determine the immunogenicity of certain vaccines in protecting against meningitis B (MenB) in young adults who have previously received a different MenB vaccine. The main questions it aims to answer are: * How many participants are protected against four key types of MenB bacteria before and after getting the new vaccine? * How strong is the immune response after vaccination, and how many people show a noticeable boost in immune response?
Trial Details
NCT Number NCT07197762
Lead Sponsor Emory University
Collaborators: Pfizer
Conditions Neisseria Meningitidis
Enrollment 125 participants
Start Date 2025-11-04
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-22